Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH)

Summary

This is a multicenter, open-label extension (OLE), single-arm study designed to assess the long-term safety and tolerability of oral IKT-001 administered once daily.

Timeline

Start

2026-10-23

Primary completion

2030-06-30

Completion

2030-12-30

Drugs

Indications